Ms Alice M Mazzella, | |
9304 Medical Plaza Dr Ste D, Charleston, SC 29406-9143 | |
(843) 863-5600 | |
(843) 553-2123 |
Full Name | Ms Alice M Mazzella |
---|---|
Gender | Female |
Speciality | Nurse Practitioner |
Experience | 40 Years |
Location | 9304 Medical Plaza Dr Ste D, Charleston, South Carolina |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023452992 | NPI | - | NPPES |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Coastal Carolina Multispecialty Associates Llc | 9931105046 | 46 |
News Archive
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration has accepted for review the company's supplemental new drug application for COPAXONE (glatiramer acetate injection) 40mg/ 1mL, a higher concentration dose of COPAXONE that offers a less frequent three times a week dosing regimen administered subcutaneously for patients with relapsing-remitting multiple sclerosis.
Roche announced today at the 51st Meeting of the American Society of Hematology (ASH) in New Orleans, LA (USA) that the pivotal Phase III study CLL8 showed that patients with previously-untreated chronic lymphocytic leukemia (CLL) survived their disease longer when treated with Rituxan (rituximab) compared to chemotherapy alone.
Doctors should advise overweight moms considering another pregnancy to take off extra weight first because they are at greater risk of having big babies, a new Saint Louis University study finds.
Northwestern University researchers has identified what they believe is a built-in biological mechanism that prevents kidney damage in the early stages of diabetes associated with obesity.
› Verified 5 days ago
Entity Name | Coastal Carolina Multispecialty Associates Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1518079102 PECOS PAC ID: 9931105046 Enrollment ID: O20061012000646 |
News Archive
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration has accepted for review the company's supplemental new drug application for COPAXONE (glatiramer acetate injection) 40mg/ 1mL, a higher concentration dose of COPAXONE that offers a less frequent three times a week dosing regimen administered subcutaneously for patients with relapsing-remitting multiple sclerosis.
Roche announced today at the 51st Meeting of the American Society of Hematology (ASH) in New Orleans, LA (USA) that the pivotal Phase III study CLL8 showed that patients with previously-untreated chronic lymphocytic leukemia (CLL) survived their disease longer when treated with Rituxan (rituximab) compared to chemotherapy alone.
Doctors should advise overweight moms considering another pregnancy to take off extra weight first because they are at greater risk of having big babies, a new Saint Louis University study finds.
Northwestern University researchers has identified what they believe is a built-in biological mechanism that prevents kidney damage in the early stages of diabetes associated with obesity.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Ms Alice M Mazzella, 9304 Medical Plaza Dr Ste D, Charleston, SC 29406-9143 Ph: (843) 863-5600 | Ms Alice M Mazzella, 9304 Medical Plaza Dr Ste D, Charleston, SC 29406-9143 Ph: (843) 863-5600 |
News Archive
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration has accepted for review the company's supplemental new drug application for COPAXONE (glatiramer acetate injection) 40mg/ 1mL, a higher concentration dose of COPAXONE that offers a less frequent three times a week dosing regimen administered subcutaneously for patients with relapsing-remitting multiple sclerosis.
Roche announced today at the 51st Meeting of the American Society of Hematology (ASH) in New Orleans, LA (USA) that the pivotal Phase III study CLL8 showed that patients with previously-untreated chronic lymphocytic leukemia (CLL) survived their disease longer when treated with Rituxan (rituximab) compared to chemotherapy alone.
Doctors should advise overweight moms considering another pregnancy to take off extra weight first because they are at greater risk of having big babies, a new Saint Louis University study finds.
Northwestern University researchers has identified what they believe is a built-in biological mechanism that prevents kidney damage in the early stages of diabetes associated with obesity.
› Verified 5 days ago
Marsha Susan Voges, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 4115 Dorchester Road, Concentra Medical Center, Charleston, SC 29405 Phone: 843-554-6737 Fax: 843-554-3356 | |
Mrs. Pamela Staker, MSN, FNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 109 Bee St, Charleston, SC 29401 Phone: 843-577-5011 | |
Karen D Doll, ANP, CVNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: Medical University Of South Carolina, 114 Doughty Street Suite 654, Charleston, SC 29424 Phone: 843-876-4854 Fax: 843-876-4413 | |
Julie Mackay Hughes, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2070 Northbook Blvd, Ste A16, Charleston, SC 29405 Phone: 843-818-6102 | |
Kristen Slagel Garrett, CPNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2051 Charlie Hall Blvd, Charleston, SC 29414 Phone: 843-573-2535 Fax: 843-573-2534 | |
Lindsey Hendrickson, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 | |
Mrs. Erin Kosak, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 109 Wappoo Creek Dr, Charleston, SC 29412 Phone: 843-796-7171 Fax: 843-795-7171 |